Chronic Pain

The latest webinar covered five studies on cannabis for various conditions including hypermobility, eczema, Parkinson’s disease, and other conditions.

Patients in Australia with chronic health conditions evaluated the effects on their quality of life, changes in pain, and more after 12 months of medical cannabis.

A survey of veterans with chronic pain revealed common use of cannabis and other natural products for various conditions.

Four terpenes were tested for their effects in management of post-operative and fibromyalgia pain.

This recently published study examined the effects of personalized coaching on the use of medical cannabis for chronic pain.

This webinar discussed recent research on medical cannabis for conditions such as alcohol use disorder and chronic pain, directed for attendees of all backgrounds.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic pain and potential benefits.

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.

In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.

A recently published observational study examined the risks of medical cannabis for developing various heart conditions.

A recent study explored cannabinoids as an alternative treatment for neuropathic pain from spinal cord injuries.

A study involving cannabigerol (CBG) injections in mice tested the effectiveness in pain reduction.

Whether someone is struggling with acute or chronic pain, cannabis can be a powerful tool as an alternative or adjunct treatment.

While placebo-controlled randomized trials are lacking, a few early studies show promise for cannabis and arthritis, and surveys show that many arthritis patients are already finding relief using cannabis to treat their symptoms.

This article features real-life stories from a cannabis patient as well as an on-the-ground cannabis nurse.

Katherine Golden, RN and CEO, executive director, and founder of Leaf411, provides a summary on the evidence surrounding cannabis as a treatment for chronic pain patients.

Based on his 13 years of clinical experience, Dr. Dustin Sulak explains strategies in effectively treating chronic pain while reducing or eliminating adverse effects.

A United Kingdom study revealed an association between cannabis products, improved quality of life, and reduced opioid use in chronic pain patients.

The Texas House approved a bill that would allow for more access to the state’s medical cannabis program.

To help clinicians and patients navigate cannabinoid-based medications (CBM), Cannabis and Cannabinoid Research published guidelines based on reviews of studies on CBM and chronic pain.

A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.

One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.

When a patient isn’t able to access the care or medication that they need in their home country, they aren’t left with much of a choice but to travel to a country that will give them the treatment they need. In part II of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), continues discussing her journey to health, the broken healthcare system hurting medical cannabis patients in the US, and what needs to change to make access better for patients.